Literature DB >> 30091057

p47phox-/- Chronic Granulomatous Disease Patient with Incomplete Kawasaki Disease.

Gouri P Hule1, Purva R Kanvinde2, Manasi A Kulkarni1, Karin van Leeuwen3, Martin de Boer3, Umair Ahmed Bargir1, Prasad D Taur2, Mukesh M Desai2, Manisha R Madkaikar4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30091057     DOI： 10.1007/s10875-018-0532-9

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  12 in total

1.  Kawasaki disease in a patient with Wiskott-Aldrich syndrome: an increase in the platelet count.

Authors:  Chihiro Kawakami; Munenori Miyake; Hiroshi Tamai
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

2.  Immunoglobulin resistance in Kawasaki disease with chronic granulomatous disease.

Authors:  Mitsuru Tsuge; Yusuke Shigemitsu; Yasuyuki Yano; Michimasa Fujiwara; Takayuki Miyai; Koso Ueda; Keisuke Takata; Tadashi Moriwake
Journal:  Pediatr Int       Date:  2012-06       Impact factor: 1.524

3.  Incomplete Kawasaki disease in a patient with chronic granulomatous disease.

Authors:  Jun Muneuchi; Masataka Ishimura; Hidetoshi Takada; Takayuki Hoshina; Rina Utsunomiya; Kazuyuki Ikeda; Kenichiro Yamaguchi; Shouichi Ohga; Koichi Kusuhara; Toshiro Hara
Journal:  Pediatr Int       Date:  2010-06       Impact factor: 1.524

Review 4.  Molecular diagnosis of chronic granulomatous disease.

Authors:  D Roos; M de Boer
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

5.  Chronic granulomatous disease: Clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients.

Authors:  Baruch Wolach; Ronit Gavrieli; Martin de Boer; Karin van Leeuwen; Sivan Berger-Achituv; Tal Stauber; Josef Ben Ari; Menachem Rottem; Yechiel Schlesinger; Galia Grisaru-Soen; Omar Abuzaitoun; Nufar Marcus; Ben Zion Garty; Arnon Broides; Jakov Levy; Polina Stepansky; Amos Etzioni; Raz Somech; Dirk Roos
Journal:  Am J Hematol       Date:  2016-11-18       Impact factor: 10.047

Review 6.  A child with X-linked agammaglobulinemia and Kawasaki disease: an unusual association.

Authors:  Dhrubajyoti Sharma; Sandesh Guleria; Deepti Suri; Amit Rawat; Ravinder Garg; Surjit Singh
Journal:  Rheumatol Int       Date:  2017-04-01       Impact factor: 2.631

Review 7.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

8.  Diabetes, renal and cardiovascular disease in p47 phox-/- chronic granulomatous disease.

Authors:  Jennifer W Leiding; Beatriz E Marciano; Christa S Zerbe; Suk See Deravin; Harry L Malech; Steven M Holland
Journal:  J Clin Immunol       Date:  2013-02-06       Impact factor: 8.317

9.  Clinical, Immunological, and Molecular Findings of Patients with p47phox Defect Chronic Granulomatous Disease (CGD) in Indian Families.

Authors:  Manasi Kulkarni; Mukesh Desai; Maya Gupta; Aparna Dalvi; Prasad Taur; Antony Terrance; Sunil Bhat; Mamta Manglani; Revathi Raj; Ira Shah; Manisha Madkaikar
Journal:  J Clin Immunol       Date:  2016-10-03       Impact factor: 8.317

10.  Chronic granulomatous disease associated with atypical Kawasaki disease.

Authors:  M A Yamazaki-Nakashimada; N Ramírez-Vargas; J De Rubens-Figueroa
Journal:  Pediatr Cardiol       Date:  2007-08-04       Impact factor: 1.838
View more
  1 in total

Review 1.  Kawasaki disease and immunodeficiencies in children: case reports and literature review.

Authors:  Francisco Rivas-Larrauri; Lorena Aguilar-Zanela; Paola Castro-Oteo; Luis Adrian Rosales-Hernandez; Francisco Otero-Mendoza; Gabriela López-Herrera; Javier Ordoñez-Ortega; Martín Garrido-García; Marco Antonio Yamazaki-Nakashimada
Journal:  Rheumatol Int       Date:  2019-07-16       Impact factor: 3.580
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.